Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine

Psychopharmacology

Volumn 156, Issue 1, 2001, Pages 73-78

  Inder, W J ^a   Prickett, T C R ^a   Mulder, Roger T ^b   Donald, R A ^a   Joyce, Peter R ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Arginine vasopressin; Corticotropin; Cortisol; Depression; Fluoxetine; Nortriptyline

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; FLUOXETINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ANALYSIS OF VARIANCE; ARGININE VASOPRESSIN; DEPRESSION; FEMALE; FLUOXETINE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; STATISTICS, NONPARAMETRIC;

EID: 0034933967     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100737     Document Type: Article

References (41)

1. The oCRH stimulation test before and after clinical recovery from depression
2. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review
3. Effects of long-term treatment with antidepressant drugs on propiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats
4. Modulation of glucocorticoid receptor gene expression by antidepressant drugs
5. Regulation of corticosteroid receptor gene expression in depression and antidepressant action
6. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects
7. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralo-corticoid receptor gene expression in rat brain. Therapeutic implications
8. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications
9. Urinary free cortisol in depression
10. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression
11. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls
12. Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex
13. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood
14. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease
15. Cortisol secretion in endogenous depression. I. Basal plasma levels
16. Cortisol secretion in endogenous depression. II. Time-related functions
17. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
18. Magnocellular axons in passage through the median eminence release vasopressin
19. Neuroendocrinology of mood disorders
20. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes
21. Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression
22. Effect of an osmotic stimulus on the secretion of arginine vasopressin and adrenocorticotropin in the horse
23. Predictors of drug response in depression
24. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: Blunted temperature and hormone responses to ipsapirone challenge
25. Production of a monoclonal antibody to cortisol: Application to a direct enzyme-linked immunosorbent assay of plasma
26. Plasma levels of arginine vasopressin elevated in patients with major depression
27. HPA axis abnormalities in depressed patients with normal response to the DST
28. Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans
29. Augmentation of the response to CRF in man: Relative contributions of endogenous angiotensin and vasopressin
30. Serotonergic regulation of type II corticosteroid receptor binding in hippocampal cell cultures: Evidence for the importance of serotonin-induced changes in cAMP levels
31. Corticosteroid receptor function is decreased in depressed patients
32. Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: Evidence for increased ACTH pulse frequency
33. Directional pituitary blood flow: A microcinephotographic study
34. Pituitary-adrenal axis rhythm disturbances in psychiatric depression
35. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression
36. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man
37. Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant
38. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: Implications for the pathophysiology of depression
39. Use of in situ hybridization to investigate the regulation of hippocampal corticosteroid receptors by monoamines
40. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis
41. Plasma ACTH levels in depression before and after recovery: Relationship to the dexamethasone suppression test